Shares of Cardinal Health, Inc. (NYSE:CAH – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the fourteen research firms that are presently covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $157.43.
Several research analysts have recently issued reports on the company. Evercore ISI restated an “outperform” rating and issued a $180.00 price objective (up from $175.00) on shares of Cardinal Health in a research note on Thursday, June 12th. Morgan Stanley set a $181.00 price objective on Cardinal Health and gave the stock an “overweight” rating in a research note on Friday, June 13th. Citigroup reissued a “neutral” rating and set a $170.00 price target (up from $157.00) on shares of Cardinal Health in a research report on Friday, June 13th. Bank of America raised their price target on shares of Cardinal Health from $165.00 to $170.00 and gave the stock a “buy” rating in a research report on Tuesday, June 10th. Finally, Wells Fargo & Company raised shares of Cardinal Health from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $136.00 to $179.00 in a report on Tuesday, June 3rd.
Check Out Our Latest Report on CAH
Hedge Funds Weigh In On Cardinal Health
Cardinal Health Stock Down 1.4%
Shares of Cardinal Health stock opened at $163.08 on Friday. The firm has a market capitalization of $38.92 billion, a P/E ratio of 25.44, a PEG ratio of 1.85 and a beta of 0.66. The company has a 50 day moving average price of $149.53 and a 200 day moving average price of $134.05. Cardinal Health has a 52 week low of $93.17 and a 52 week high of $166.32.
Cardinal Health (NYSE:CAH – Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.15 by $0.20. The business had revenue of $54.88 billion during the quarter, compared to analysts’ expectations of $55.33 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 68.84%. The business’s quarterly revenue was up .0% on a year-over-year basis. During the same quarter last year, the company posted $2.08 earnings per share. As a group, research analysts anticipate that Cardinal Health will post 7.95 earnings per share for the current fiscal year.
Cardinal Health Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be paid a $0.5107 dividend. This represents a $2.04 annualized dividend and a dividend yield of 1.25%. The ex-dividend date of this dividend is Tuesday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s payout ratio is currently 31.51%.
Cardinal Health Company Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Recommended Stories
- Five stocks we like better than Cardinal Health
- Conference Calls and Individual Investors
- New All-Time Highs Coming for Broadcom? Wall Street Says Yes
- Industrial Products Stocks Investing
- Overheated Market? Analysts Watch These Red Flags
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- 3 Reasons AMD Could Be the Hottest Stock of the Summer
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.